5 September 2025
Chairman Shareholding
In order to provide liquidity to satisfy institutional demand, Martyn Ratcliffe, Executive Chairman, has sold 1,450,000 shares via Panmure Liberum at a price of 550 pence per share. Following this transaction, Mr Ratcliffe will retain a holding of 8,042,080 shares (including 80,000 shares held in a SIPP), equivalent to 18.2% of the voting rights of Science Group (excluding Treasury Shares). All other Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.
The Board is pleased to welcome a number of new institutional shareholders onto the Science Group share register. The broader shareholder base strengthens the platform for the next phase of the development of the Group.
| - Ends - For further information:
| |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name: Martyn Ratcliffe | ||||
| 2. | Reason for the notification | ||||
| a) | Position/status: Executive Chairman | ||||
| b) | Initial notification/Amendment: Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name: Science Group plc | ||||
| b) | LEI: 2138009OJQT79BDB3E93 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument: Ordinary shares of 1p each. Identification code: GB00B39GTJ17 | ||||
| b) | Nature of the transaction: Sale of shares | ||||
| c) | Price(s) and volume(s):
| ||||
| d) | Aggregated information: · Aggregated volume: 1,450,000 · Price: £7,975,000 | ||||
| e) | Date of the transaction: 4 September 2025 | ||||
| f) | Place of the transaction: AIMX |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.